Skip to content

Smith & Wesson Brands, Inc. SWBI Increase Decrease In Accrued Liabilities And Deferred Revenue

Increase Decrease In Accrued Liabilities And Deferred Revenue at other companies

Immunome logo
ImmunomeIMNM
-$9.75M-14.4%
Sutro Biopharma logo
Sutro BiopharmaSTRO
$8.4M+51.3%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$3.27M+59.2%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$5.15M-142%
Cerus logo
CerusCERS
-$7.53M-210%
UMH
UMH PropertiesUMH
-$522K+85.4%

Other financials

Income statement

See full
Revenue$178.4M+26.7%
Gross profit$53.1M+30.9%
Operating income$21.3M+62.6%
Net income$16.2M+87.9%
EPS (diluted)$0.36+89.5%

Balance sheet

See full
Cash & equivalents$28.2M+11.7%
Total debt$53.1M-53.8%
Total equity$376.6M+1.1%
Total assets$512.8M-8.4%

Cash flow

See full
Operating cash flow$74.6M
CapEx$4.8M-33.7%
Free cash flow$69.7M

Valuation

See full
Market cap$701.77M+81.5%
Enterprise value$726.72M+52.5%
P/E38×+9.2×
P/S1.3×+0.5×

Profitability

See full
Gross margin26.9%+0.1pp
Operating margin5.6%+0.5pp
Net margin3.5%+0.7pp
FCF margin17.3%

Returns & leverage

See full
Return on equity4.9%+1.5pp
Debt / equity0.1×-0.2×
Current ratio3.2×-1.0×

Where this comes from

Reported directly by Smith & Wesson Brands, Inc. in its filing.

Tagged under the XBRL concept swbi:IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue.

The official record: Smith & Wesson Brands, Inc.’s 10-Q, filed September 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue?
Smith & Wesson Brands, Inc. (SWBI) reported increase decrease in accrued liabilities and deferred revenue of -$4.09M in Q2 2025.
How has Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue changed year-over-year?
Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue decreased by 877.9% year-over-year, from $526K to -$4.09M.
What is the long-term trend for Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue?
Over 2 years (2021 to 2024), Smith & Wesson Brands, Inc.'s increase decrease in accrued liabilities and deferred revenue has grown at a -61.6% compound annual growth rate (CAGR), from -$27.06M to $4M.
What does increase decrease in accrued liabilities and deferred revenue mean?
This represents the net change in short-term obligations and revenue received in advance of service or product delivery. It serves as a measure of working capital efficiency and the timing of cash receipts relative to performance obligations.